Nova Eye Medical Limited (ASX:EYE)
Australia · Delayed Price · Currency is AUD 0.1400
+0.0050 (3.70%)
Sep 17, 2026, 3:53 PM AEST
Nova Eye Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Nova Eye Medical stock has a consensus rating of "Buy" and an average price target of $0.43. The average 1-year stock price forecast is 207.14% higher than the current stock price, while the lowest is $0.33 (+135.71%) and the highest is $0.52 (+271.43%).
Price Target: $0.43 (+207.14%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nova Eye Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
42.60M
from 34.87M
Increased by 22.19%
Revenue Next Year
51.30M
from 42.60M
Increased by 20.42%
EPS This Year
-0.01
from -0.02
EPS Next Year
0.01
from -0.01
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.